InvestorsHub Logo
Followers 242
Posts 12284
Boards Moderated 0
Alias Born 08/14/2003

Re: A deleted message

Sunday, 02/23/2020 5:39:03 PM

Sunday, February 23, 2020 5:39:03 PM

Post# of 203913
This is one of the times I can agree, the development of virtually any oncology product is exceptionally expensive and time taking, largely because it takes so long to prove you actually have a benefit that's meaningful.

Fortunately, just the opposite should be true for psoriasis in the case of a topical cream for it. In a matter or days or weeks improvement should be clear. The FDA may want a number of months to prove it's durable, but it won't take years, to even decades as some oncology products due. Then it should be possible to permit the earnings from the psoriasis cream to fund the MM trial, at least in part. A substantially higher stock price could certainly fund it with some dilutive funding as well. Investors may not like dilution, but when the share price reaches high single digit to low double digit dollars, I don't believe investors will mind.

I believe there is other good news on many of the products the company is working on. Once patent approvals come it, the trial process for the conditions they're directed at may be longer than psoriasis, but it's nowhere near as long, or expensive as going after MM or other cancers.

I suspect that once more is known about patent, and trials of the cream, the likelihood of a BP partnering with OWCP will be far greater, and that too will greatly take care of funding for the companies many products.

Gary